NewAmsterdam Pharma Company N.V. (NAMS) reported Q1 Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| NAMSCO Corporation (NASDAQ: NAMS) | Delayed: 20.03 +0.47 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.56 | 52 Week High | $0.00 | |||
| Open | $19.74 | 52 Week Low | $0.00 | |||
| Day High | $20.46 | P/E | N/A | |||
| Day Low | $19.59 | EPS | $0.00 | |||
| Volume | 26,290 | |||||
